[Short, medium and long-term benefits of human milk intake in very-low-birth-weight infants]

Bibiana Chinea Jiménez1, Yumana Awad Parada, Antonio Villarino Marín

  • 1Hospital Universitario La Paz. bibianachineajimenez@gmail.com.

Nutricion Hospitalaria
|November 14, 2017
PubMed

Insights

Human milk feeding for very low birth weight infants reduces hospital stay and improves head circumference and cognitive development at five years. Encouraging maternal milk is vital for enhanced infant neurodevelopment.

Area of Science:

  • Neonatal care
  • Pediatric nutrition
  • Developmental pediatrics

Background:

  • Very low birth weight (VLBW) infants (<1,500 grams) require specialized neonatal intensive care.
  • Nutritional strategies significantly impact VLBW infant outcomes.
  • Long-term growth and neurodevelopmental follow-up is crucial for VLBW infants.

Purpose of the Study:

  • To evaluate the impact of human milk feeding in the early weeks of life on VLBW infants.
  • To assess effects on weight gain, hospitalization duration, and nutritional status at discharge.
  • To determine long-term effects on growth and neurodevelopment at two and five years.

Main Methods:

  • A longitudinal study followed VLBW infants admitted to a Neonatal Intensive Care Unit.
  • Infants were classified by feeding type at discharge: exclusive human milk, formula, or mixed.
  • Anthropometric measurements and neurodevelopmental assessments (Bayley scale, Kaufman test) were conducted at 2 and 5 years.

Main Results:

  • Infants fed human milk during initial admission had a shorter hospital stay.
  • Human milk intake was associated with larger head circumference at 2 and 5 years.
  • A better global and verbal cognitive score was observed at five years in infants receiving human milk.

Conclusions:

  • Human milk feeding during initial neonatal admission is associated with improved long-term neurodevelopmental outcomes.
  • Maternal milk consumption positively influences cognitive function in VLBW infants by age five.
  • Encouraging human milk feeding in VLBW infants is recommended to foster better neurodevelopment.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
88.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
334
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
338